Fred Eshelman

Investor type:

Social media:

Available after registration.

Past investments

  • Cellective BioTherapy
  • Dignify Therapeutics
  • G1 Therapeutics
  • Kinnate Biopharma
  • Aruna Biomedical
  • Sapience Therapeutics
  • Innocrin Pharmaceuticals